Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The CEO botched this release, should have kept quiet he killed the positive move up on investors anticipation. He sewed confusion and uncertainty into what was a natural market move up.
The recent Form 4s show Options are “A” Accumulated Gray paid $5.77 for his now owns 101,000 shares. The other two filings the same “A”
The last Conference Call I believe they said the rods will be in testing this year
should be ready for a commercial test in 2022.
Don’t over look that the company only has 5,630,000 shares outstanding. The float must tiny and will be explodsive on any positive news.
This a good place to track GDLNF Environmental and public hearings with the Gov of Greenland.
https://naalakkersuisut.gl/en/Hearings/Hearing-Archive/2020/1812_kuannersuit
Was submitted the week after 11/16/20 to US and International agencies. Expect responses after 30 days of receipt by agencies, any day now.
Company News release: 11/16/20
Trial Application (CTA) has been submitted to the governing health agency, with a U.S. Investigational New Drug (IND) application also to be submitted this week to the FDA. Both these submissions are part of final preparations for the Company’s multinational Phase 2 clinical trial of Brilacidin for COVID-19, which is on track to commence in 2020 upon gaining required approvals
They’ve raised “ we have sold $12,027,029 of shares” according to this form.
Lightbridge Corporation
Up to $2,623,700
Common Stock
We have entered into an At-the-Market Equity Offering Sales Agreement, or sales agreement, with Stifel, Nicolaus & Company, Incorporated (the “Agent”), dated May 28, 2019, relating to the sale of shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, under this prospectus supplement and accompanying prospectus we may offer and sell shares of our common stock, $0.001 par value per share, having an aggregate offering price of up to $2,623,700 from time to time through the Agent, acting as agent, including $1,472,971 of shares of common stock originally registered by the prospectus supplement dated May 28, 2019 and an additional $1,150,729 of shares of common stock initially registered hereby. As of the date of this prospectus supplement, we have sold $12,027,029 of shares of common stock pursuant to the sales "
.
Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus will be made by any method permitted that is deemed an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. The Agent is not required to sell any specific amount, but will act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
The Agent will be entitled to compensation at a commission rate of up to 4.0% of the gross sales price per share sold. In connection with the sale of the common stock on our behalf, the Agent will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of the Agent will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to the Agent with respect to certain liabilities, including liabilities under the Securities Act.
Our common stock is listed on the Nasdaq Capital Market under the symbol “LTBR”. On October 8, 2020, the last reported sale price of our common stock on the Nasdaq Capital Market was $3.20 per share.
The aggregate market value of our outstanding common stock held by non-affiliates, or public float, is approximately $38.6 million, based on approximately 5.4 million shares of outstanding common stock on October 9, 2020, of which 25,541 shares are held by affiliates, and a price of $7.15 per share, which was the closing price of our common stock on the Nasdaq Capital Market on August 10, 2020. We have sold $10,236,741 of securities as calculated pursuant to General Instruction I.B.6 of Form S-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus supplement. In no event will we sell securities in public primary offerings on Form S-3 with a value exceeding more than one-third of our public float (as defined by General Instruction I.B.6) in any 12 calendar month period so long as our public float remains below $75 million.
My whole family takes NAC Since Cov2 was shown to cause ROS. (Reactive Oxydative Stress), and thats why I invest in RVVTF it works.
We also take mega doses of Vitamins C,D,ZINC, And Quecetin
Epidemiologists have been begging the FDA since February to issue a EUA for rapid (2- 10 minute ) cheap ($1-$3) test, thousands of infectious could have been detected if these test were given 2x a day. The FDA has slow walked the process so the Pres stepped in to open the economy and save lives.
This video explains what those scientists have been discussing for months.
That would be about 70 to 80% of the infected patients.
Thanks will change.
Relief’s Science is the real deal, unfortunately it has huge dilution.
The Science as to why it’s a Game Changer!
This video is circulating among epidemiologist. They want a rapid test even if it is not sensitive. Ours will be both. The FDA is already moving in that direction.
Hopeful
From the May press release we can see that the funding is the issue and from your link we can see it’s MYMX technology
This collaboration is supported through the combined resources of Mymetics, Baylor and Texas's Children's Center for Vaccine Development and covers the initial preclinical development. To speed-up the development of a potential Covid-19 vaccine, Mymetics and Baylor are seeking additional funding opportunities to start in parallel the GMP manufacturing and preparations for clinical trials. The aim is to have a virosome-based Covid-19 vaccine candidate evaluated in humans within 12 months.
Great for you. I never quite paid up enough to get any substantial position.
The FDA just remodeled their guidelines for at home test
This gives Todos’ Saliva 2 minute test more importance.
The FDA continues to help facilitate innovation in test development, thereby enhancing Americans' access to COVID-19 tests. The recommendations provided today are intended to help get tests to market that are simple enough to use at home, similar to a pregnancy test. We hope that with the innovation we've seen in test development, we could see tests that you could buy at a drug store, swab your nose or collect saliva, run the test, and receive results within minutes at home, once these tests become available. These types of tests will be a game changer in our fight against COVID-19 and will be crucial as the nation looks toward reopening."
Stephen M. Hahn, M.D, FDA Commissioner
https://www.news-medical.net/news/20200729/FDA-posts-new-template-for-over-the-counter-COVID-19-diagnostic-tests.aspx
Wrong they shipped their first tests on May 18 2020
TODOS MEDICAL LTD.
EXPLANATORY NOTE
On May 18, 2020, Todos Medical Ltd. announced its first commercial sale of COVID-19 tests. The sale was made via a sub-distribution agreement with a U.S.-based medical distribution company with clients in state and local governments throughout the Southeastern United States who are seeking comprehensive testing solutions for Return-to-Work programs.
This report on Form 6-K (including the exhibits hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
EXHIBITS
Exhibit
Number
Description
99.1 Press Release dated May 18, 2020
Just open an account with TD Ameritrade for free and use their Thinkorswim app.
https://start.tdameritrade.com/select?entity=103
You are absolutely Right my bad I apologize to the board.
Here’s my first post :
dayneyus Friday, 05/29/20 12:47:24 PM
Re: None 0
Post # of 3096
Why Bucillamine could be a blockbuster : Physicians are beginning to realize Severe Covid 19 patients are suffering (ROS) Reative Oxidative Species, this condition is countered by Glutathione. It is the bodies most powerful antioxidant. N Acetyl Cysteine (NAC) is given to counter ROS. Bucillamine is 16 times more effective than N Acetyl Cysteine it’s a no brainer for FDA to grant Phase3. This will save people and needs to be out there agaist SARS-COV 2.
The following video shows the Science behind it:
Thank you Gio, GOD bless you, I have my niece taking NAC,high doses of Vitamin D /C and Zinc at home. Her husband is in intensive care.
No those time rules are before OWS, its up to the company. I was buying before the run up, into the run up and after the run up, now at 90K want more but lost confidence in management.
They received the clearance to enter Phase 3, judging from their news release, way back in April 23/2020 and took till June 30 to file. That why I am concerned with their ability to move theis golden opportunity. Not only for my portfolio but the drug is desperately needed. My niece and her husband have contacted Cov2 a week ago they are elderly with very negative prognosis..
I thought Operaton Warpspreed cleared all that nonsense
https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html
What’s the plan and what’s happened so far?
Development: To accelerate development while maintaining standards for safety and efficacy, OWS has been selecting the most promising countermeasure candidates and providing coordinated government support.
Protocols for the demonstration of safety and efficacy are being aligned, which will allow the trials to proceed more quickly, and the protocols for the trials will be overseen by the federal government, as opposed to traditional public-private partnerships, in which pharmaceutical companies decide on their own protocols. Rather than eliminating steps from traditional development timelines, steps will proceed simultaneously, such as starting manufacturing of the vaccine at industrial scale well before the demonstration of vaccine efficacy and safety as happens normally. This increases the financial risk, but not the product risk.
I have no doubt the drug will work it’s the management team, I worry about. Look how long the took to file the IND!
There are over 2000 testing locations in the USA, plus popup testing.CVS alone has 1400 rapid test sites (30 min.) not to mention hospitals and labs, I counted over 19 lab venders in Santa Clara County where I live holding drive through testing.
https://cvshealth.com/covid-19/testing-information-locations
There are over 2000 testing sites in the USA, CVS alone has 1400 rapid test(30 minute) plus hospital and private labs. https://cvshealth.com/covid-19/testing-information-locations
I received a Covid test results in 24 hrs from Kaiser Foundation,Todos Medical can process 1000000 test a week is working on a 2 min saliva Covid test, Univ. Arizona is offering 100,000 saliva Covid test to Phoenix residents, UC Berkeley is developing a Rapid saliva test . I can’t see testing as a limiting factor
You are right this drug will keep most out of hospital and Rescue most of the hospitalized. This Medcram video
Shows the Mechanism of Action, Dr. Selhuelt recommends N-Acetyl Cysteine to boost glutathione, he probably dose not know about Bucillamine. I will post a comment on his YouTube channel about it.
The latest company presentation:
http://www.ggg.gl/assets/Uploads/Presentations/2020/16e8cc7762/20200303_PDAC-Greenland-Session.pdf
Canarc a lot like Balmoral who was bought out by Wallbridge very nice return the market didn’t understand the trade and it became undervalued. See the same for: WHGOF, AGCBF the latter is nearing feasibility and mining permit.
This time we may see a partner for Polaris. With gold this high it becomes feasible. May see a $1 share price?
They are within 8 weeks of getting the green light for licensing the mine.
https://wcsecure.weblink.com.au/pdf/GGG/02230190.pdf
https://wcsecure.weblink.com.au/pdf/GGG/02237258.pdf
Why Bucillamine could be a blockbuster : Physicians are beginning to realize Severe Covid 19 patients are suffering (ROS) Reative Oxidative Species, this condition is countered by Glutathione. It is the bodies most powerful antioxidant. N Acetyl Cysteine (NAC) is given to counter ROS. Bucillamine is 16 times more effective than N Acetyl Cysteine it’s a no brainer for FDA to grant Phase3. This will save people and needs to be out there agaist SARS-COV 2.
The following video shows the Science behind it:
It’s the whole USA Uranium sector that’s on steroids because the President’s initiative to make USA independent
In nuclear fuel.
I see they are thinking of inhalation but with the latest info from MedCram.com on their Covid updates. it appears the virus uses the lungs to invade the Endothelium knocking out the Ace II receptor precipitating a cascade into Oxdative Stress , hence blood clots vascular stress.
In view of that an IV along with inhalation seems more logical as B has been used as IV for ABSSSI and in IV form it gets to the area of most need. Medcram has reviews on why use of Ventilators not been a successful treatment.
What is required to develop a mulberry leaf source:
https://blog.usejournal.com/mo-mulberry-the-essential-guide-to-all-you-need-to-know-about-mulberry-28a0c11b611
A recent presentation of there holding
https://whitegoldcorp.ca/_resources/fact-sheet/White-Gold-Corp-Fact-Sheet.pdf
Anybody here following "WHGOF"? A really prospective junior with big mining partners. 24%insider ownership.
https://www.youtube.com/channel/UCTjCesi7VVwpTvpCscvXtzA
https://whitegoldcorp.ca/_resources/fact-sheet/White-Gold-Corp-Fact-Sheet.pdf
This guy ,Shawn Ryan, is the prospector, genius, behind the great properties White has acquired.
https://www.youtube.com/channel/UCTjCesi7VVwpTvpCscvXtzA
This company has Avery compelling history and Avery large land package.
https://www.youtube.com/channel/UCTjCesi7VVwpTvpCscvXtzA
Not a med pro, but I understand the escalation is being used to test the delivery method for safety and seeing if any severe reaction to the drug vs the placebo is observed. The gamma scintigraphy evaluates each escalation dose for site delivery effectiveness. The results of those scintigraphies will be released a few weeks after the close of trial.